
Biomedicine in Reverse
May 22, 2014 Justin Chakma examines why expenditure on biomedical R&D has been falling rapidly.
Justin Chakma is an investor with Thomas, McNerney & Partners, a life sciences venture capital firm.
May 22, 2014 Justin Chakma examines why expenditure on biomedical R&D has been falling rapidly.